The company also performs highly in Governance of Access. Johnson & Johnson (2nd) demonstrates strong performance in all three Technical Areas and performs well across all assessment criteria including access strategies, R&D access planning and capacity building.ĪstraZeneca (3rd) has newly joined the top three, ranking as the number one company in the Product Delivery Technical Area by excelling in its approach to patent transparency and technology transfers. It is also in the top three of the other two Technical Areas, and its access-to-medicine strategy is central to its approach to ensuring that medicines reach those that need them most. The company develops treatments and vaccines for diseases that disproportionally affect people in LMICs. GSK (1st) tops both the overall ranking and the R&D sub-ranking. Novartis comes 4th notably, in 2022 it became the first company to agree to a non-exclusive voluntary licence for a medicine to treat a non-communicable disease. GSK and Johnson & Johnson complete the top three, performing well across all assessment criteria, including equitable access strategies. It has made progress by licensing and transferring technology for its COVID-19 vaccine. Product DeliveryĪstraZeneca takes the top spot in Product Delivery, leading in its approach to patent transparency and sharing of intellectual property assets. Out of all 20 companies, GSK has the largest number of projects in development that target priority diseases such as malaria and HIV/AIDS. Johnson & Johnson and Novartis also engage in R&D for priority diseases, with both companies having access plans for LMICs covering all late-stage R&D projects in the pipeline. The top spot is retained by GSK, followed closely by Johnson & Johnson and Novartis. Joint for second place are AstraZeneca, GSK, Johnson & Johnson, Novo Nordisk, Sanofi and Takeda. The company provides evidence of well-established structures of governance and management, with responsibility assigned and access-to-medicine incentives offered at the highest level, It takes a strong approach to ensuring ethical business practices, and also has stringent compliance processes across its operations.
0 kommentar(er)
